Dibenzepin hydrochloride, a tricyclic antidepressant, was
introduced in 1968 for the treatment of depressive illness. By 1973 its use in
Sweden had been associated with an unexpectedly high number of suicide
attempts which led to its withdrawal in that country. Although its use has lapsed in
several countries, it remains available in at least eight European countries.
